J&J COVID-19 vaccine protects against breakthrough infections, study says – National | Globalnews.ca

Johnson & Johnson said on Thursday that a real-world study showed its single-shot COVID-19 vaccine protects against breakthrough infections and hospitalizations for up to six months.

The study, sponsored by the vaccine developer, was conducted between Jan. 1 and Sept. 7 last year, before the Omicron variant was discovered. It is also yet to be peer-reviewed.

Read more:

COVID-19 vaccine maker Johnson & Johnson splitting into two companies

J&J said protection against infection from its single dose vaccine starts to wane only from the fourth month compared to the second month in the case of two-dose vaccines from rivals Pfizer Inc and BioNTech’s as well as Moderna .

No waning of protection was found for ICU admissions for all the three vaccines, J&J said. The company said the study was carried out by collecting claims and laboratory data covering 168 million people.

Story continues below advertisement


Click to play video: 'U.S. doctors fear COVID-19 cases will surge after holidays'







U.S. doctors fear COVID-19 cases will surge after holidays


U.S. doctors fear COVID-19 cases will surge after holidays

 




For all the latest health News Click Here 

Read original article here

Denial of responsibility! TechAI is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.